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ABSTRACT  
Anti-inflammatory activity of ethanolic extract of roots, stems and leaves Mimosa hamata was investigated at the doses of 200 and 400 mg/kg 
using carrageenan induced paw edema and cotton pellet granuloma technique in albino rats. The stem extracts showed significan t activity in 
dose dependent manner as compared to control group. The observations suggested that the extract of M. hamata were effective in exudative 
and proliferative phases of inflammation i.e. in acute and chronic inflammation. The results obtained indicate that M. hamata has an anti-
inflammatory activity that supports the folk medicinal use of the plant.  
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INTRODUCTION:- 
Inflammation is defined as the local response of living 
mammalian tissues to injury due to any agent. It is a body 
defence reaction to prevent the spread of injurious agent 
and to remove the necrosed cells and tissues. Inflammation 
may be caused by like bacteria, viruses, fungi, parasites, 
antigen-antibody reaction. Mechanical trauma, organic and 
inorganic poisons and  foreign bodies. Inflammation involves 
two basic processes early inflammatory response later 
followed by healing. Signs of inflammation include redness, 
swelling, heat, pain, loss of function. There are two types of 
inflammation, Acute and Chronic. Acute inflammation is of 
short duration and represents the early body reaction, 
resolves quickly and is usually followed by healing. Chronic 
inflammation is defined as prolonged process in which 
tissue destruction and inflammation occur at same time.1 
1. An acute transient phase characterised by local 
vasodilation and increased capillary permeability. 
2. A subacute phase, characterised by infilteration of 
leukocytes and phagocytic cells. 
3. A chronic proliferative phase, in which tissue 
degeneration and fibrosis occurs1. 
Genus Mimosa (family: Mimosaceae) has about 400 species 
which are mainly shrubs & small trees in tropics. About 8 
species are found in India, with medicinal importance2 while 
some are of ornamental use. Mimosa pudica the curious 
plant in the genus is a creeping form. Because of the way it 
folds its leaves when touched, it is known as touch-me-not 
plant. Mimosa hamata also folds its leaves when touched3. 
Mimosa hamata is a much straggling shrub occurring in 
tropics & widely distributed in India & Pakistan4. The plant 
is used for urinary complaints & as a tonic against general 
weakness. A paste of leaves is applied over glandular 
swellings & is used in dressing for sinus, sores & piles5. Its 
roots possess contraceptive efficacy while seeds are used as 
blood purifier6. Various bioefficacies viz., antifungal activity 
of deprotenized leaf extract7,8 . Antibacterial activity of 
alcoholic extract of aerial parts, antiviral activity of 
methanolic extract of roots2 and Antioxidant activity9 have 
been reported. 
The major phytoconstituents present in Mimosa hamata 
(Willd.) include 4-ethylgallic acid from fresh flowers, 
triterpene saponin B (3-O-Larabinosyl-D-glucosyl morolic 
acid), mimonoside A, B, C and saponin A (3-O-D-glucosyl-L-
rhamnosyl morolic acid) from the roots, ethylgallate and 
gallic acid from leaves.13 
The plant Mimosa hamata (Willd.) belonging to the family 
Mimosaceae is being selected for phytochemical 
investigations to pin point various pharmacological 
activities. The said plant has been reported to possess 
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antibacterial, antiviral & antioxidant properties.7,8,2,9 . It was 
found that no substantial work of the plant was carried out 
for its anti-inflammatory activity. 
MATERIALS AND METHODS 
Plant material:- 
For the present study roots, stems and leaves of M. hamata 
plant was collected from Methwade, Tal. Sangola, Dist. 
Solapur (Maharashtra) and was authenticated at Botanical 
Survey of India, Pune. The voucher specimen will be 
deposited in the institution and in ‘Herbarium’ Department 
of Botany, Solapur University, Solapur during the month of 
September 2015. The plant material was dried under shade 
at room temperature for about 15 days. The dried plant 
samples were powdered by mechanical grinder and sieved 
to give particle size 40- 100 mm. The powder was stored in 
polythene bags at room temperature before extraction.  
Preparation of Alcoholic extract: 
The collected roots, stems and leaves were shade dried, 
reduced to a coarse powder in a mechanical grinder to 
obtain of desired particle size (40# sieve).About 200 gm of 
powdered material was subjected to exhaustive extraction 
with 90% alcohol in a soxhlet extractor at a temperature of 
60 – 70 0C, concentrated on a rotary flash evaporator at 50 
0C (Superfit, India), and finally to dry powder. Some part of 
the total extract was reserved for phytochemical 
investigation and rest of the extract was used for biological 
activity.  
Preliminary phytochemical analysis: 
The ethanolic extract was then subjected to preliminary 
phytochemical analysis to assess the presence of various 
phytoconstituents; it revealed the presence of flavonoids, 
carbohydrate, glycosides, tannins. Preliminary Thin layer 
chromatography studies also confirmed these constituents 
10. 
Animals: Wistar albino rats weighing 175-225g of either sex 
maintained under standard husbandary conditions (temp 
23±2oC, relative humidity 55±10% and 12 hours light dark 
cycle) were used for the screening. Animals were fed with 
standardlaboratory food and ad libitum during the study 
period. The experiments were performed after the 
experimental protocols approved by the institutional animal 
ethics committee, India 2009. 
Toxicity studies: Acute toxicity study was performed for 
ethanolic extract according to the acute toxic classic method 
as per OECD guidelines11. Female albino rats were used for 
acute toxicity study. The animals were kept fasting for 
overnight providing only water, after which dose of 
300mg/kg was administered orally and observed for 14 
days. If mortality was observed in two animals out of three 
animals, then the dose administered was assigned as toxic 
dose. If the mortality was observed in one animal, then the 
same dose was repeated to confirm the toxic dose. If 
mortality was not observed, the procedure was repeated for 
further higher doses such 50, 200 & 2000mg/kg body 
weight. The animals were observed for toxic symptoms for 
72 h 12. 
Preparation of carrageenan suspension 
Suspension of carrageenan sodium salt 1% was prepared by 
sprinkling 100mg of carrageenan powder in 10 mL of saline 
(0.9% NaCl) and set aside to soak for 1 hour, and then the 
suspension was mixed thoroughly using magnetic stirrer. 
 
Preparation of sodium CMC suspension 
Stock suspension of sodium CMC was prepared by 
triturating the powder sodium CMC (1g) finely in 2.5 ml of 
water, 1:10 dilution of this stock solution made in distilled 
water was used for suspending the test and standard drugs. 
A) Evaluation of acute anti-inflammatory activity:- 
Carrageenan induced rat paw oedema model 14. 
Among the many methods used for screening of anti-
inflammatory drugs, one of the most commonly used 
techniques is based upon the ability of such agents to inhibit 
the oedema produced in the hind paw of the rat after 
injection of phlogistic agent. Various measuring systems 
used for the assessment of induced oedema in the paw 
include: volume, paw thickness, paw weight and painfulness 
to monitor the development of the induced oedema in the 
paw. Acute hind paw oedema is induced either in mice or in 
rats by injecting 0.05mL to 0.1mL of 1%w/v carrageenan 
which reaches a peak oedema level at 2-3hrs after 
carrageenan injection. Although oedema can be induced by 
many other phlogistic agents like dextran, formaldehyde, 5- 
hydroxytryptamine, histamine, bradykinin, prostaglandin E1 
etc for routine screening, carrageenan induced oedema 
model is employed. 
Anti-inflammatory activity was assessed using carrageenan 
induced rat paw oedema method. The ethical clearance was 
obtained before the experiment from the Institutional 
Animal Ethics Committee (Registration number 
1406//PO/a/11/CPCSEA). The male Wistar rats, weighing 
between 100-150g, were procured from National Toxicology 
Centre, Pune and housed in Animal House of Sahyadri 
College of Pharmacy, Methwade, Sangola. Rats were kept in 
the polypropylene cages and fed on a standard laboratory 
diet with water ad libitum. The animals were exposed to 
alternate cycle of 12 h of darkness and light each. Rats were 
divided into 9 groups of six animals each.  
Group I: Rats were served as control. 
Group II : Rats were received 0.1 ml of 1% carrageenan 
(s.c.),2.5 ml of 0.5% w/v sodium carboxy methyl cellulose 
(C.M.C); p.o.   
Group III: Rats were received Aceclofenac sodium (10 
mg/kg/p.o.) 
Group IV: Rats were received 1.0ml of ethanolic extract of  
stems  of Mimosa hamata (200 mg/kg/o.p)  
Group V : Rats were received 1.0ml of ethanolic extract of 
stems of Mimosa hamata (400mg/kg/o.p) 
Group VI: Rats were received 1.0ml of ethanolic extract of 
leaves of Mimosa hamata (200 mg/kg/o.p)  
Group VII: Rats were received 1.0ml of ethanolic extract of 
leaves of Mimosa hamata (400mg/kg/o.p) 
Group VIII: Rats were received 1.0ml of ethanolic extract of 
roots of Mimosa hamata (200 mg/kg/o.p)  
Group IX : Rats were received 1.0ml of ethanolic extract of 
roots of Mimosa hamata (400mg/kg/o.p) 
One hour later, the rats of group III, IV, V were challenged by 
subcutaneous injection of 0.1 ml of 1%w /v solution of 
carrageenan into the planter side of the left hind paw. The 
paw was marked with ink at the level of lateral malleolus 
and immersed in mercury up to this mark. The paw volume 
was measured plethysmographically immediately after 
injection (0 h) and followed by every hour till the 6th hr 
after injection of carrageenan to each group. The paw 
volume up to the tribiotural articulation was measured at 0, 
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1, 2, 3, 4 and 5th hours. The difference between the initial 
and subsequent reading gave the actual oedema volume. 
Percent inhibition of inflammation was calculated using the 
formula, 
% Edema Inhibition = Vc-Vt/Vc × 100 
where 'Vc' represents oedema volume in control and 'Vt', 
oedema volume in group treated with test extracts. The 
values obtained from each group were expressed as Mean ± 
Standard deviation. Dunnet’s t- test was done to compare the 
statistical significant changes between control, Carrageenan 
induced paw odema, Aceclofenac treatment rats and with 
extract treatment. The significant levels between the groups 
was compared using row wise comparison between Initial 
with different hours. 
 
Anti-inflammatory activity by carrageenan induced paw edema:- 
Sr. No. Test Material  Mean increase in paw volume ± SEM 
1 hr 2 hr 3 hr 4 hr 5 hr 
1 Control 0.24  ±0.01 0.24 ±0.01 0.24 ±0.01 0.24 ±0.01 0.24 ±0.01 
2 Carrageenan (1% w/v) 0.69  ± 0.06 1.11 ± 0. 04 1.87 ± 0.04 2.09  ± 0.06 1.98 ± 0.07 
3 Aceclofenac (10mg) 0.57 ± 0.04 
(17 %)  
0.45 ± 0.07 
(59 %) 
0.37 ±0.02* 
(80.21%) 
0.34  ± 0.05** 
(83.73%) 
0.29  ± 0.03*** 
(85.35%)  
4 ESMH (200mg/kg) 0.64 ± 0.01 
(7%) 
0.58 ± 0.05 
(47 %) 
0.52 ± 0.04 
(72.19%) 
0.47± 0.05* 
(77.51%) 
0.40 ± 0.05** 
(79.79%) 
5 ESMH (400 mg/kg) 0.61 ± 0.03 
(11%) 
0.56  ± 0.08 
(49.54%) 
0.49 ± 0.06 
(73.79%) 
0.42 ± 0.04** 
(79.90%) 
0.37 ± 0.03** 
(81.31%) 
6 ELMH (200mg/kg) 0.67 ± 0.03 
(3%) 
0.62 ± 0.08 
(44.14%)  
0.59 ±0.02 
(68.44%) 
0.56 ± 0.03* 
(73.20%) 
0.52 ± 0.01* 
(73.73%) 
7 ELMH (400 mg/kg) 0.65 ± 0.04  
(5%) 
0.61 ± 0.06 
(45.04%) 
0.57 ± 0.04 
(69.51%) 
0.53 ± 0.09* 
(74.64%)  
0.49 ± 0.04** 
(75.25%) 
8 ERMH (200 mg/kg) 0.68 ± 0.07 
(1.44%) 
0.6 4 ± 0.03 
(42.34%) 
0.60 ±0.07* 
(67.91%) 
0.57 ± 0.01* 
(72.72%) 
0.53 ± 0.08* 
(73.23%) 
9 ERMH (400 mg/kg) 0.65 ± 0.05 
(5%) 
0.61 ± 0.05 
(45.04%) 
0.56±0.04* 
(70.05%) 
0.51 ± 0.09* 
(75.59%) 
0.47 ± 0.07** 
(76.25%) 
Statistical analysis was carried out by ANOVA followed by the Dunnet’s test at the significance level of p<0.01 
 
Groups Initial paw volume 5 hr  Difference in Paw Inhibition percentage 
Control 0.24  ±0.01 0.24  ±0.01 0.00 - 
Carrageenan (1% w/v) 0.69  ± 0.06 1.98 ± 0.07 1.29 - 
Aceclofenac (10mg) 0.57 ± 0.04 
(17 %)  
0.29  ± 0.03*** 
(85.35%)  
0.28 49.12% 
ESMH (200mg/kg) 0.64 ± 0.01 
(7%) 
0.40 ± 0.05** 
(79.79%) 
0.24 37.5% 
ESMH (400 mg/kg) 0.61 ± 0.03 
(11%) 
0.37 ± 0.03** 
(81.31%) 
0.24 39.34% 
ELMH (200mg/kg) 0.67 ± 0.03 
(3%) 
0.52 ± 0.01* 
(73.73%) 
0.15 22.38% 
ELMH (400 mg/kg) 0.65 ± 0.04  
(5%) 
0.49 ± 0.04** 
(75.25%) 
0.16 24.61% 
ERMH (200 mg/kg) 0.68 ± 0.07 
(1.44%) 
0.53 ± 0.08* 
(73.23%) 
0.15 22.05% 
ERMH (400 mg/kg) 0.65 ± 0.05 
(5%) 
0.47 ± 0.07** 
(76.25%) 
0.18 27.69% 
n = 6, * - P <0.05, **P<0.001 compared to control, standard drug 
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STATISTICAL ANALYSIS  
The statistical analysis of the evaluation of the anti-
inflammatory activity of ethanolic extract of leaves, roots and 
stems of Mimosa hamata against the carrageenan induced 
paw oedema in albino rats were analyzed using ANOVA 
followed by Dunnett’s t test and expressed as mean ± SEM. 
B) Evaluation of chronic anti-inflammatory activity:- 
Cotton pellet induced granuloma15:- 
The method of Winter and Porter was used to study chronic 
inflammation in rats 
Albino Wistar rats were randomly divided into eight groups 
of six animals in each group were taken anaesthetized with 
ether. The axillary skin was shaved and disinfected with 70% 
ethanol. An incision was made and by a blunt forcep 
subcutaneous tunnels were formed and a sterilized cotton 
pellet (50±1mg) was placed in both axillas. All the animals in 
each group were treated in the following way 
Group-1: Served as Toxicant control, which received orally 
1ml/kg of 1% sodium CMC solution daily for 8 days following 
subcutaneous implantation of cotton pellets.  
Group-2: Termed as Standard and received Aceclofenac 
sodium 10mg/kg p.o. once daily orally for 8 days following 
subcutaneous implantation of cotton pellets.  
Group-3: Received 200mg/kg stems extract of Mimosa 
hamata once daily orally for 8 days following subcutaneous 
implantation of cotton pellets.  
Group-4: Received 400mg/kg stems extract of Mimosa 
hamata once daily orally for 8 days following subcutaneous 
implantation of cotton pellets.  
Group-5: Received 200mg/kg roots extract of Mimosa 
hamata once daily orally for 8 days following subcutaneous 
implantation of cotton pellets.  
Group-6: Received 400mg/kg roots extract of Mimosa 
hamata once daily orally for 8 days following subcutaneous 
implantation of cotton pellets.  
Group-7: Received 200mg/kg leaves extract of Mimosa 
hamata once daily orally for 8 days following subcutaneous 
implantation of cotton pellets.  
Group-8: Received 400mg/kg leaves extract of Mimosa 
hamata once daily orally for 8 days following subcutaneous 
implantation of cotton pellets.  
On the 9th day, the animals were sacrificed by cervical 
dislocation and blood was collected by cardiac puncture. The 
cotton pellets along with granuloma tissue were removed 
and weighed immediately for wet weight. The pellets were 
dried in an oven at 60°C until a constant weight was 
obtained.  
The granuloma tissue formation and exudate formation was 
calculated using the following formulae:  
Measure of granuloma tissue formation = constant dry 
weight – initial weight of pellet Measure of exudate 
formation = wet weight of pellet - constant dry weight of 
pellet. 
 The level of inhibition of granuloma tissue development was 
calculated using the expression:  
% inhibition of granuloma tissue formation=  WgrC-WgrT X 100      
                    WgrC                                 
Where, WgrC = weight of granuloma tissue of the Toxicant 
control group; WgrT = weight of granuloma tissue of the 
treatment group 
 
Effect of stems, roots and leaves of M. hamata in Cotton Pellet Granuloma Method  
Gr. No. Treatment (mg/kg) Increase in weight of pellets (mg) % inhibition  
1.  Distilled water 58.56 ± 0.39 - 
2.  Aceclofenac sodium (10mg/kg) 30.02 ± 1.19*** 48.73 
3. ESMH (200mg/kg) 35.18 ± 0.26* 39.92 
4.  ESMH (400mg/kg) 33.54 ± 0.3** 42.72 
5.  ERMH(200mg/kg) 50.42 ± 0.52 13.9 
6.  ERMH(400mg/kg) 48.38 ± 0.31 17.38 
7. ELMH(200mg/kg) 51.24 ± 1.06 12.5 
8. ELMH (400 mg/kg) 49.73 ± 0.83 15.07 
 
 
Statistical Analysis:  
Values are expressed as Mean ± SEM, n=6 in each group. Data 
was analyzed by one way ANOVA followed by Dunnett’s Test. 
*P < 0.01 as compared to control group, that means 
statistically significant. 
RESULTS:-  
Preliminary phytochemical screening of ethanolic extract of 
the leaves, stems and roots of Mimosa hamata (Willd.) 
revealed the presence of bioactive components like 
flavanoids, carbohydrate, glycosides and tannins. 
Carrageenan induced paw edema model was used for the 
evaluation of anti‐inflammatory activity of the ethanolic 
extract of M. hamata roots, leaves and stems. There was a 
dose‐dependent, significant reduction in 
carrageenan‐induced rat paw edema at 200 and 400 mg/kg 
of extract and at 10 mg/kg Aceclofenac over a period of 5 hrs 
as shown in Table . 
Carrageenan induced edema is commonly used as an 
experimental animal model for acute inflammation and is 
believed to be biphasic, of which the first phase is mediated 
by the release of histamine and kinins and then 
prostaglandin in the later phase. So, the effect of the 
ethanolic extract against inflammations produced by these 
individual mediators was studied. 
Flavonoids and other phenolics compounds of plant origin 
have been reported as antioxidants and as scavengers of free 
radicals. Considering that antioxidants can also exert 
anti‐inflammatory effects.  
In the carrageenan induced acute inflammation,  
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Group 3 treated rats (i.e. standard drug Aceclofenac in a dose 
of 10 mg/kg, b.w., p.o., treated rats) showed significant 
activity (p<0.001) at 1st and 2nd  hour with respective 
percentage inhibitions of 17% and 59% with respect to 
Group-1 rats ( i. e. controlled rats ). It showed highly 
significant(p< 0.001) activity starting from 3rd and lasting up 
to 6th hour. The percentage inhibitions were observed to be 
80.21%, 83.73%, 85.35 respectively 
Group 4 rats (i.e. ethanol extract of stems of Mimosa hamata 
200 mg per kg b.w., p.o.) showed significant activity from 1st 
and 2nd  hour with respect to percentage inhibition of 7% 
and 47.00% when compared to Group-1 rats (i. e. controlled 
rats). The extract appears to show highly significant activity 
from 3rd to 5th with percentage and division of extract 
72.19%, 77.51%, 79.79% 
Group-5 rats (i.e. ethanol extract of stems of Mimosa hamata 
in a dose of 400 mg/kg b.o. p.o) showed significant anti-
inflammatory activity at 1st and 2nd hour with percentage 
inhibition of 11% and 49.54% when compared to group -1 
rats (i.e. controlled rats). The extract appeared to showed 
highly significant activity from 3rd to 5th hr with respect to 
73.79%, 79.90%, 81.31% when compared to group-1 rats 
(i.e. controlled rats) 
Group- 6 rats (i.e. ethanolic extract of leaves of Mimosa 
hamata 200 mg/kg b.w.p.o. ) appears to show significant 
anti-inflammatory activity a 1st and 2nd hour with percentage 
inhibition of  3% and  44.14 % respectively. It appears to 
show a highly significant (p<0.001) anti-inflammatory 
activity from 3rd to 5th hour with respect to percentage 
inhibition of 68.44%, 73.20%,73.73% when compared to 
group -1 rats (i.e controlled rats) 
Group- 7 rats (i.e. ethanolic extract of leaves of Mimosa 
hamata 400 mg/kg b.w.p.o. ) appears to show significant 
anti-inflammatory activity a 1st and 2nd hour with percentage 
inhibition of  5% and  45.04 % respectively. It appears to 
show a highly significant (p<0.001) anti-inflammatory 
activity from 3rd to 5th hour with respect to percentage 
inhibition of 69.51%, 74.64%, 75.25% when compared to 
group -1 rats (i.e controlled rats) 
Group- 8 rats (i.e. ethanolic extract of roots of Mimosa 
hamata 200 mg/kg b.w.p.o. ) appears to show significant 
anti-inflammatory activity a 1st and 2nd hour with percentage 
inhibition of  1.44% and  42.34 % respectively. It appears to 
show a highly significant (p<0.001) anti-inflammatory 
activity from 3rd and 5th hour with respect to percentage 
inhibition of 67.91%, 72.72%, 73.23% when compared to 
group -1 rats (i.e controlled rats) 
Group- 9 rats (i.e. ethanolic extract of roots of Mimosa 
hamata 400 mg/kg b.w.p.o. ) appears to show significant 
anti-inflammatory activity a 1st and 2nd hour with percentage 
inhibition of  5% and  45.04 % respectively. It appears to 
show a highly significant (p<0.001) anti-inflammatory 
activity from 3rd and 5th hour with respect to percentage 
inhibition of 70.05%, 75.59%,76.26% when compared to 
group -1 rats (i.e controlled rats) 
The cotton-pellet granuloma is widely used to evaluate the 
transudative and proliferative components of the chronic 
inflammation. The moist weight of the pellets correlates with 
transuda, the dry weight of the pellet correlates with the 
amount of granulomatous tissues16,17. Chronic inflammation 
occurs by means of the development of proliferate cells. 
These cells can be either spread or in granuloma form. Non-
steroidal anti-inflammatory drugs decrease the size of 
granuloma which results from cellular reaction by inhibiting 
granulocyte infiltration, preventing generation of collagen 
fibers and suppressing mucopolysaccharides18,19 order to 
assess the efficacy of the extract against proliferative phase 
of inflammation, we selected carrageenan-induced air-pouch 
model in which tissue degradation and fibrosis occurs. 
During the repair process of inflammation, there is 
proliferation of macrophages, neutrophils, fibroblasts and 
multiplication of small blood vessels occurs, which are the 
basic sources of forming a highly vascularised reddish mass, 
termed granulation tissue20,21. Thus, in this model the extract 
significantly reduced infiltration of macrophages, monocytes, 
neutrophils and others. These results indicate that the 
extract may alter the action of endogenous factors that are 
involved in  the  migration of these substances to the site of 
inflammation. The extract showed significant P < 0.01 anti-
inflammatory activity in cotton wool induced granuloma and 
thus found to be effective in chronic inflammatory condition, 
which reflected its efficacy in inhibiting the increase in the 
number of fibroblasts and synthesis of collagen and 
mucopolysaccharides during granuloma tissue formation. 
Chronic inflammatory conditions was induced in animals by 
inserting the cotton pellets subcutaneously. The results of 
cotton pellet granuloma method revealed that ethanolic 
extract of stems 400mg/kg of Mimosa hamata (Willd.) was 
found to decrease the weight of granuloma significantly 
(42.72%) than the ethanolic extract of stems of M hamata at 
200mg/kg (39.92%) 
 
DISCUSSION: 
A large number of herbal drugs are reputed to have excellent 
medicinal value, and are in use for the treatment of several 
ailments. In folk medicine, various indigenous drugs are 
used, in single and/or in combined forms, for treating 
different types of inflammatory and arthritic conditions, with 
considerable success. Although the use of these drugs has a 
sound tradition, and their medicinal uses and general safety 
are well known to native people, their use has yet to be 
rationalized in therapeutics, using the current methodology. 
Scientific studies are therefore required to assess their safety 
and efficacy. Inflammation is associated with various clinical 
conditions like arthritis, cancer and vascular diseases. Anti-
inflammatory drugs, presently available for the treatment of 
inflammation of various kinds, have undesirable side effects 
such as causing peptic ulcers. Therefore efforts are focused 
on obtaining plant derived anti-inflammatory agents, which 
are as potent as the currently available NSAID’s. An attempt 
was made in our laboratory to evaluate anti-inflammatory 
activity of extracts of stems, roots and leaves of Mimosa 
hamata (Willd.).  
According to the phytochemical evaluation studies 
performed on stems, roots and leaves of Mimosa hamata 
(Willd.) revealed the presence of compounds like flavonoids, 
carbohydrate, glycosides and tannins. 
Acute anti-inflammatory activity can be evaluated by using 
rat paw edema which can be induced by carrageenan, 
histamine, albumin, etc. Chronic inflammatory conditions can 
be induced in animals by inserting the cotton pellets 
subcutaneously.  
 In the present study, the acute anti-inflammatory activity of 
ethanolic extracts of Mimosa hamata (Willd.) roots, stems 
and leaves was assessed by carrageenan induced rat paw 
edema.  
Standard drug, Aceclofenac sodium, which is a NSAID, 
appears to show significant (p<0.01) inhibition of first phase 
and highly significant (p<0.01) inhibition of second phase, 
indicating its effectiveness as NSAID in acute inflammation. 
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Ethanolic extracts of stems of Mimosa hamata have shown 
significant (p<0.01) anti-inflammatory activity. Ethanolic 
extract of stems at 200 mg/kg showed the maximum effect at 
3rd hr (72.19%) while ethanolic extract at 400 mg/kg 
showed the maximum effect at 5th hr (81.31%) in 
comparison with standard Aceclofenac (85.35%). Hence both 
the extracts were found to be effective in chronic 
inflammation.  
Our investigation revealed that the ethanolic extract of stems 
of Mimosa hamata 200 mg/kg and 400 mg/kg are having 
highly significant inhibition (p<0.01) from 3rd and 5th hour 
indicating the possible inhibition of mediator of acute 
inflammation in this phase i.e. prostaglandin. 
In the present study, the chronic anti-inflammatory activity 
of ethanolic extracts of Mimosa hamata (Willd.) roots, stems 
and leaves was assessed by cotton pellet granuloma. The 
ethanolic extract of stems 400 mg/kg of Mimosa hamata 
(Willd.) was found to decrease the weight of granuloma 
significantly (42.72%) than the ethanolic extract of stems of 
M hamata at 200 mg/kg ( 39.92%) 
From the above studies it is quite apparent that the ethanolic 
extract of stems of Mimosa hamata 200 mg/kg and 400 
mg/kg was found to be effective in both acute and chronic 
inflammatory models and cotton pellet granuloma model 
compared to ethanolic extract of leaves and roots. In both 
model they exhibited anti-inflammatory effect in a dose 
dependent manner which can be comparable with that of 
Aceclofenac. The study justifies its use in inflammation as 
suggested in the folklore medicines. 
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